1. Home
  2. APVO vs AGRZ Comparison

APVO vs AGRZ Comparison

Compare APVO & AGRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$4.85

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

AGRZ

Agroz Inc. Ordinary Shares

N/A

Current Price

$0.34

Market Cap

7.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
APVO
AGRZ
Founded
2016
2020
Country
United States
Malaysia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
8.3M
7.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
APVO
AGRZ
Price
$4.85
$0.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.8K
242.3K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
0.13
N/A
EPS
N/A
N/A
Revenue
$3,114,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.15
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.33
52 Week High
$13.11
$7.20

Technical Indicators

Market Signals
Indicator
APVO
AGRZ
Relative Strength Index (RSI) 46.89 39.32
Support Level $3.88 $0.33
Resistance Level $5.66 $0.61
Average True Range (ATR) 0.32 0.04
MACD -0.00 -0.00
Stochastic Oscillator 43.43 15.38

Price Performance

Historical Comparison
APVO
AGRZ

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

Share on Social Networks: